These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 31958078)

  • 1. STAT3 signaling statuses determine the fate of resveratrol-treated anaplastic thyroid cancer cells.
    Wu J; Li YT; Tian XT; Liu YS; Wu ML; Li PN; Liu J
    Cancer Biomark; 2020; 27(4):461-469. PubMed ID: 31958078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual Inhibition of BRAF-MAPK and STAT3 Signaling Pathways in Resveratrol-Suppressed Anaplastic Thyroid Cancer Cells with BRAF Mutations.
    Lu MD; Li H; Nie JH; Li S; Ye HS; Li TT; Wu ML; Liu J
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol Suppresses the Growth and Enhances Retinoic Acid Sensitivity of Anaplastic Thyroid Cancer Cells.
    Li YT; Tian XT; Wu ML; Zheng X; Kong QY; Cheng XX; Zhu GW; Liu J; Li H
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29596381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of Reactive Oxygen Species Levels with Resveratrol Sensitivities of Anaplastic Thyroid Cancer Cells.
    Zheng X; Jia B; Tian XT; Song X; Wu ML; Kong QY; Li H; Liu J
    Oxid Med Cell Longev; 2018; 2018():6235417. PubMed ID: 30116486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol and its Nanoparticle suppress Doxorubicin/Docetaxel-resistant anaplastic Thyroid Cancer Cells
    Xiong L; Lin XM; Nie JH; Ye HS; Liu J
    Nanotheranostics; 2021; 5(2):143-154. PubMed ID: 33457193
    [No Abstract]   [Full Text] [Related]  

  • 6. Wnt/β-catenin signaling is a therapeutic target in anaplastic thyroid carcinoma.
    Diaz D; Bergdorf K; Loberg MA; Phifer CJ; Xu GJ; Sheng Q; Chen SC; Byrant JM; Tigue ML; Hartmann H; Rohde SL; Netterville JL; Baregamian N; Goettel JA; Ye F; Lee E; Weiss VL
    Endocrine; 2024 Oct; 86(1):114-118. PubMed ID: 38806891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological implications of PTEN upregulation and altered sodium/iodide symporter intracellular distribution in resveratrol-suppressed anaplastic thyroid cancer cells.
    Xiong L; Nie JH; Lin XM; Wu JB; Chen Z; Xu B; Liu J
    J Cancer; 2020; 11(23):6883-6891. PubMed ID: 33123279
    [No Abstract]   [Full Text] [Related]  

  • 8. Signal transducer and activator of transcription 3 inhibition alleviates resistance to BRAF inhibition in anaplastic thyroid cancer.
    Wang Y; Hu Z; Ma W; Niu Y; Su J; Zhang L; Zhao P
    Invest New Drugs; 2021 Jun; 39(3):764-774. PubMed ID: 33245464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiated anti-tumor effects of BETi by MEKi in anaplastic thyroid cancer.
    Zhu X; Park S; Lee WK; Cheng SY
    Endocr Relat Cancer; 2019 Sep; 26(9):739-750. PubMed ID: 31272080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting signal transducer and activator of transcription 3 pathway by cucurbitacin I diminishes self-renewing and radiochemoresistant abilities in thyroid cancer-derived CD133+ cells.
    Tseng LM; Huang PI; Chen YR; Chen YC; Chou YC; Chen YW; Chang YL; Hsu HS; Lan YT; Chen KH; Chi CW; Chiou SH; Yang DM; Lee CH
    J Pharmacol Exp Ther; 2012 May; 341(2):410-23. PubMed ID: 22328572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking CDK7-Mediated NOTCH1-cMYC Signaling Attenuates Cancer Stem Cell Activity in Anaplastic Thyroid Cancer.
    Doolittle WKL; Zhao L; Cheng SY
    Thyroid; 2022 Aug; 32(8):937-948. PubMed ID: 35822558
    [No Abstract]   [Full Text] [Related]  

  • 12. KLF5 influences cell biological function and chemotherapy sensitivity through the JNK signaling pathway in anaplastic thyroid carcinoma.
    Wang Z; Qiu X; Zhang H; Li W
    J Biochem Mol Toxicol; 2020 May; 34(5):e22469. PubMed ID: 32173973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BET bromodomain inhibitor JQ1 modulates microRNA expression in thyroid cancer cells.
    Mio C; Conzatti K; Baldan F; Allegri L; Sponziello M; Rosignolo F; Russo D; Filetti S; Damante G
    Oncol Rep; 2018 Feb; 39(2):582-588. PubMed ID: 29251329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis.
    Sadowski SM; Boufraqech M; Zhang L; Mehta A; Kapur P; Zhang Y; Li Z; Shen M; Kebebew E
    Oncotarget; 2015 Jul; 6(20):18038-49. PubMed ID: 25945839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA PTCSC3 affects drug resistance of anaplastic thyroid cancer through STAT3/INO80 pathway.
    Wang XM; Liu Y; Fan YX; Liu Z; Yuan QL; Jia M; Geng ZS; Gu L; Lu XB
    Cancer Biol Ther; 2018 Jul; 19(7):590-597. PubMed ID: 29561707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PIAS3, SHP2 and SOCS3 Expression patterns in Cervical Cancers: Relevance with activation and resveratrol-caused inactivation of STAT3 signaling.
    Zhang P; Yang B; Yao YY; Zhong LX; Chen XY; Kong QY; Wu ML; Li C; Li H; Liu J
    Gynecol Oncol; 2015 Dec; 139(3):529-35. PubMed ID: 26432044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol induces differentiation markers expression in anaplastic thyroid carcinoma via activation of Notch1 signaling and suppresses cell growth.
    Yu XM; Jaskula-Sztul R; Ahmed K; Harrison AD; Kunnimalaiyaan M; Chen H
    Mol Cancer Ther; 2013 Jul; 12(7):1276-87. PubMed ID: 23594881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Krüppel-Like Factor 4 in the Maintenance of Chemoresistance of Anaplastic Thyroid Cancer.
    Lee SI; Kim DK; Seo EJ; Choi EJ; Kwon YW; Jang IH; Lee JC; Kim HY; Shong M; Kim JH; Kim SJ
    Thyroid; 2017 Nov; 27(11):1424-1432. PubMed ID: 28920531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PP121, a dual inhibitor of tyrosine and phosphoinositide kinases, inhibits anaplastic thyroid carcinoma cell proliferation and migration.
    Che HY; Guo HY; Si XW; You QY; Lou WY
    Tumour Biol; 2014 Sep; 35(9):8659-64. PubMed ID: 24867098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ophiopogonin D' inhibited tumour growth and metastasis of anaplastic thyroid cancer by modulating JUN/RGS4 signalling.
    Xu T; Zhang W; Zhang Y; Song F; Huang P
    J Cell Mol Med; 2024 Aug; 28(16):e70014. PubMed ID: 39153211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.